A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure

Purpose OnabotulinumtoxinA has demonstrated efficacy and safety in the treatment of urinary incontinence (UI) associated with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (OAB); however, real-world evidence is limited. This postmarketing surveillance study aimed to assess...

Full description

Bibliographic Details
Main Authors: Kwang Jin Ko, Brenda Jenkins, Anand Patel, Kyu-Sung Lee
Format: Article
Language:English
Published: Korean Continence Society 2019-03-01
Series:International Neurourology Journal
Subjects:
OnabotulinumtoxinA
Urinary incontinence
Neurogenic urinary bladder
Overactive urinary bladder
Online Access:http://www.einj.org/upload/pdf/inj-1836176-088.pdf

Internet

http://www.einj.org/upload/pdf/inj-1836176-088.pdf

Similar Items